Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease
β Scribed by Thomas W. Mitchell; Elliott J. Mufson; Julie A. Schneider; Elizabeth J. Cochran; Jonathan Nissanov; Li-Ying Han; Julia L. Bienias; Virginia M.-Y. Lee; John Q. Trojanowski; David A. Bennett; Steven E. Arnold
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 394 KB
- Volume
- 51
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The neural basis of the amnesia characterizing early Alzheimer's disease (AD) remains uncertain. Postmortem pathological studies have suggested early involvement of the mesial temporal lobe, whereas in vivo metabolic studies have shown hypometabolism of the posterior cingulate cortex. Using a techni
Recent studies indicate that there is a marked reduction in trkA-containing nucleus basalis neurons in end-stage Alzheimer's disease (AD). We used unbiased stereological counting procedures to determine whether these changes extend to individuals with mild cognitive impairment (MCI) without dementia
Immunocytochemistry for choline acetyltransferase (ChAT) and the vesicular acetylcholine transporter (VAChT) was used to examine the expression of these linked cholinergic markers in human basal forebrain, including cases with early stages of Alzheimer's disease (AD). Previous neurochemical studies
Objective: The most common pathogenesis for familial Alzheimer's disease (FAD) involves misprocessing (or alternative processing) of the amyloid precursor protein (APP) by c-secretase due to mutations of the presenilin 1 (PS1) gene. This misprocessing/alternative processing leads to an increase in t